Brenner MK - Search Results

1

Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma.

Louis CU, Savoldo B, Dotti G, Pule M, Yvon E, Myers GD, Rossig C, Russell HV, Diouf O, Liu E, Liu H, Wu MF, Gee AP, Mei Z, Rooney CM, Heslop HE, Brenner MK. Louis CU, et al. Among authors: brenner mk. Blood. 2011 Dec 1;118(23):6050-6. doi: 10.1182/blood-2011-05-354449. Epub 2011 Oct 7. Blood. 2011. PMID: 21984804 Free PMC article. Clinical Trial.

2

A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells.

Dilloo D, Rill D, Entwistle C, Boursnell M, Zhong W, Holden W, Holladay M, Inglis S, Brenner M. Dilloo D, et al. Blood. 1997 Jan 1;89(1):119-27. Blood. 1997. PMID: 8978284 Free article.

3

CD40 ligand induces an antileukemia immune response in vivo.

Dilloo D, Brown M, Roskrow M, Zhong W, Holladay M, Holden W, Brenner M. Dilloo D, et al. Blood. 1997 Sep 1;90(5):1927-33. Blood. 1997. PMID: 9292526 Free article.

4

IL-2 adenovector-transduced autologous tumor cells induce antitumor immune responses in patients with neuroblastoma.

Bowman L, Grossmann M, Rill D, Brown M, Zhong WY, Alexander B, Leimig T, Coustan-Smith E, Campana D, Jenkins J, Woods D, Kitchingman G, Vanin E, Brenner M. Bowman L, et al. Blood. 1998 Sep 15;92(6):1941-9. Blood. 1998. PMID: 9731051 Free article.

5

Gene transfer by adenovectors.

Brenner M. Brenner M. Blood. 1999 Dec 15;94(12):3965-7. Blood. 1999. PMID: 10590039 Free article. Review. No abstract available.

6

Administration of neomycin resistance gene-marked EBV-specific cytotoxic T-lymphocytes as therapy for patients receiving a bone marrow transplant for relapsed EBV-positive Hodgkin disease.

Heslop H, Rooney C, Brenner M, Krance R, Carrum G, Gahn B, Bollard C, Khan S, Gee A, Popat U, Gresik M, Przepiorka D, Kuehnle I, Grilley B. Heslop H, et al. Hum Gene Ther. 2000 Jul 1;11(10):1465-75. doi: 10.1089/10430340050057530. Hum Gene Ther. 2000. PMID: 10910143 Clinical Trial. No abstract available.

7

Efficient infection of primitive hematopoietic stem cells by modified adenovirus.

Yotnda P, Onishi H, Heslop HE, Shayakhmetov D, Lieber A, Brenner M, Davis A. Yotnda P, et al. Gene Ther. 2001 Jun;8(12):930-7. doi: 10.1038/sj.gt.3301488. Gene Ther. 2001. PMID: 11426333

8

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.

Dotti G, Savoldo B, Takahashi S, Goltsova T, Brown M, Rill D, Rooney C, Brenner M. Dotti G, et al. Exp Hematol. 2001 Aug;29(8):952-61. doi: 10.1016/s0301-472x(01)00668-3. Exp Hematol. 2001. PMID: 11495701 Free article.

9

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Among authors: brenner mk. J Immunol. 2002 Jan 15;168(2):909-18. doi: 10.4049/jimmunol.168.2.909. J Immunol. 2002. PMID: 11777989

10

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: brenner mk. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

452 results

Search Page